Amneal and Oculus Innovative Sciences Announce Broad Multi-Market, Multi-Product Collaboration for Microcyn(R)-Based Drugs and Devices Feb 15, 2011
Oculus Innovative Sciences Receives New FDA 510(k) Clearance for Microcyn-Based Dermatology HydroGel for Management of Atopic Dermatitis, Radiation Dermatitis and Other Skin Dermatoses Feb 8, 2011
Oculus Innovative Sciences Reports Record Third Quarter Revenue for Fiscal Year 2011, Exceeding Guidance Feb 3, 2011
Oculus Innovative Sciences Announces Fiscal Third Quarter 2011 Financial Results and Conference Call Jan 20, 2011
Oculus Innovative Sciences to Present at OneMed Forum 2011 During JP Morgan Week in San Francisco Jan 6, 2011
Oculus Innovative Sciences Launches Microcyn(R)-Compatible XuSorb(TM) Foam with Waterproof Cover Wound Dressing Nov 10, 2010
Oculus Innovative Sciences Reports Record Revenue in Second Quarter Fiscal-Year 2011, Exceeding Guidance Nov 4, 2010
Oculus Innovative Sciences Announces Fiscal Second Quarter 2011 Financial Results and Conference Call Oct 26, 2010
